296 related articles for article (PubMed ID: 28179276)
1. Runx transcription factors in the development and function of the definitive hematopoietic system.
de Bruijn M; Dzierzak E
Blood; 2017 Apr; 129(15):2061-2069. PubMed ID: 28179276
[TBL] [Abstract][Full Text] [Related]
2. [Transcription factor RUNX1].
Markova EN; Petrova NV; Razin SV; Kantidze OL
Mol Biol (Mosk); 2012; 46(6):846-59. PubMed ID: 23350231
[TBL] [Abstract][Full Text] [Related]
3. Role of RUNX1 in hematological malignancies.
Sood R; Kamikubo Y; Liu P
Blood; 2017 Apr; 129(15):2070-2082. PubMed ID: 28179279
[TBL] [Abstract][Full Text] [Related]
4. A role for RUNX1 in hematopoiesis and myeloid leukemia.
Ichikawa M; Yoshimi A; Nakagawa M; Nishimoto N; Watanabe-Okochi N; Kurokawa M
Int J Hematol; 2013 Jun; 97(6):726-34. PubMed ID: 23613270
[TBL] [Abstract][Full Text] [Related]
5. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
Okumura AJ; Peterson LF; Lo MC; Zhang DE
Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052
[TBL] [Abstract][Full Text] [Related]
6. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
[TBL] [Abstract][Full Text] [Related]
7. RUNX transcription factors at the interface of stem cells and cancer.
Deltcheva E; Nimmo R
Biochem J; 2017 May; 474(11):1755-1768. PubMed ID: 28490659
[TBL] [Abstract][Full Text] [Related]
8. RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice.
Nakamura Y; Ichikawa M; Oda H; Yamazaki I; Sasaki K; Mitani K
Leuk Res; 2018 Nov; 74():14-20. PubMed ID: 30278283
[TBL] [Abstract][Full Text] [Related]
9. Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation.
Dowdy CR; Xie R; Frederick D; Hussain S; Zaidi SK; Vradii D; Javed A; Li X; Jones SN; Lian JB; van Wijnen AJ; Stein JL; Stein GS
Hum Mol Genet; 2010 Mar; 19(6):1048-57. PubMed ID: 20035012
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 translocations in malignant hemopathies.
De Braekeleer E; Férec C; De Braekeleer M
Anticancer Res; 2009 Apr; 29(4):1031-7. PubMed ID: 19414342
[TBL] [Abstract][Full Text] [Related]
11. Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesis.
Bras S; Martin-Lannerée S; Gobert V; Augé B; Breig O; Sanial M; Yamaguchi M; Haenlin M; Plessis A; Waltzer L
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4986-91. PubMed ID: 22411814
[TBL] [Abstract][Full Text] [Related]
12. RUNX1: A microRNA hub in normal and malignant hematopoiesis.
Rossetti S; Sacchi N
Int J Mol Sci; 2013 Jan; 14(1):1566-88. PubMed ID: 23344057
[TBL] [Abstract][Full Text] [Related]
13. Roles of the RUNX1 Enhancer in Normal Hematopoiesis and Leukemogenesis.
Liau WS; Ngoc PC; Sanda T
Adv Exp Med Biol; 2017; 962():139-147. PubMed ID: 28299656
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
15. Core-binding factor: a central player in hematopoiesis and leukemia.
Speck NA; Stacy T; Wang Q; North T; Gu TL; Miller J; Binder M; Marín-Padilla M
Cancer Res; 1999 Apr; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598
[TBL] [Abstract][Full Text] [Related]
16. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Engel ME; Hiebert SW
Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
[TBL] [Abstract][Full Text] [Related]
17. Alternative RUNX1 Promoter Regulation by Wnt/β-Catenin Signaling in Leukemia Cells and Human Hematopoietic Progenitors.
Medina MA; Ugarte GD; Vargas MF; Avila ME; Necuñir D; Elorza AA; Gutiérrez SE; De Ferrari GV
J Cell Physiol; 2016 Jul; 231(7):1460-7. PubMed ID: 26580584
[TBL] [Abstract][Full Text] [Related]
18. A germline point mutation in Runx1 uncouples its role in definitive hematopoiesis from differentiation.
Dowdy CR; Frederick D; Zaidi SK; Colby JL; Lian JB; van Wijnen AJ; Gerstein RM; Stein JL; Stein GS
Exp Hematol; 2013 Nov; 41(11):980-991.e1. PubMed ID: 23823022
[TBL] [Abstract][Full Text] [Related]
19. The RUNX1-PU.1 axis in the control of hematopoiesis.
Imperato MR; Cauchy P; Obier N; Bonifer C
Int J Hematol; 2015 Apr; 101(4):319-29. PubMed ID: 25749719
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
Matsumura T; Nakamura-Ishizu A; Muddineni SSNA; Tan DQ; Wang CQ; Tokunaga K; Tirado-Magallanes R; Sian S; Benoukraf T; Okuda T; Asou N; Matsuoka M; Osato M; Suda T
Blood; 2020 Oct; 136(17):1919-1932. PubMed ID: 32573733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
